Gyre Therapeutics, Inc. (GYRE)
5.91
+0.17
(+2.96%)
USD |
NASDAQ |
May 29, 16:00
5.90
-0.01
(-0.17%)
After-Hours: 20:00
Gyre Therapeutics EPS Diluted (Quarterly) : -0.0961 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1646 |
| Savara, Inc. | -0.1472 |
| Vericel Corp. | -0.1241 |
| Krystal Biotech, Inc. | 1.833 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.858M |
| Revenue (Quarterly) | 22.52M |
| Total Expenses (Quarterly) | 31.21M |
| Enterprise Value | 560.13M |
| Gross Profit Margin (Quarterly) | 94.55% |
| Profit Margin (Quarterly) | -43.78% |
| Earnings Yield | -1.32% |
| Operating Earnings Yield | 0.42% |
| Normalized Earnings Yield | -1.054 |